Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
lung disease
Marketing
Respiratory patient groups decry pricing, access to lung meds
Patient groups focused on lung diseases observed an improvement in pharma's reputation in 2022 compared to a year earlier, but some issues persist.
Ben Adams
Jul 24, 2023 7:34am
Sanofi and Regeneron enlist Broadway actor for lung health med
Oct 26, 2022 7:45am
Boehringer breathes new life into 'Breathless' campaign
Sep 22, 2022 9:20am
Mannkind wraps up phase 1 trial of inhaled lung infection asset
Sep 6, 2022 9:35am
BI lines up celebrity judges for lung disease awareness effort
May 6, 2021 8:40am
United Therapeutics seeks FDA approval of dry powder Tyvaso
Apr 26, 2021 11:58am
